<DOC>
	<DOCNO>NCT02340520</DOCNO>
	<brief_summary>This pilot study design evaluate effect theophylline roflumilast circulate Histone deacetylase ( HDAC ) level subject COPD , bronchodilator effect corticosteroid . Studies perform 10 subject COPD nonresponsive bronchodilator . Subjects receive theophylline tablet 1 week , follow measurement circulate HDAC acute effect oral prednisone bronchodilator response inhale beta agonist . Roflumilast tablets add theophylline week study repeat . The study provide preliminary data effect theophylline roflumilast circulating HDAC level effect corticosteroid beta agonist bronchodilator response COPD .</brief_summary>
	<brief_title>Enhancement Corticosteroid Efficacy COPD</brief_title>
	<detailed_description>1 . SUBJECTS : 10 Stable patient &gt; 45 year age , establish diagnosis COPD ( 18 ) , FEV1 &lt; 60 % predict , FEV1/FVC &lt; 70 % &lt; +15 % FEV1 response bronchodilator recruit . Patients gender include . 2 . TESTS ) Blood : ) HDAC 2 peripheral blood mononuclear cell : ii ) Serum theophylline level b ) Spirometry measurement FVC , FEV1 FEV1/FVC PROCEDURES Visit 1 . 1 . After provide informed consent , subject receive brief history physical examination 2 . Blood drawn peripheral vein HDAC2 level ( 2 ml ) . 3 . Each subject undergo baseline spirometry , repeat 3 inhalation albuterol inhaler . c ) Subjects ask continue regular treatment regimen , include long short act beta agonist anticholinergic , well inhaled steroid . ) Theophylline tablets extended-release 12 hr formulation , 300 mg orally take every 12 hr dispense , subject return one week later Visit 2 . The subject ask refrain use his/her long act beta agonist anticholinergics one day ( 24 hour ) prior Visit 2 , use short act beta agonist take caffeine contain drink morning visit 2 . The subject ask inform P. I. adverse event . Subjects discontinue study drug side effect withdrawn study . Visit 2 . 1 . A brief history physical examination perform subject ask change symptom . 2 . Blood ( 5 ml ) draw peripheral vein HDAC2 theophylline level 3 . After baseline spirometry subject give single dose 40 mg prednisone tablet . 4 . After 120 minute , spirometry repeat , follow 3 puff albuterol inhaler repeat spirometry . The subject ask continue theophylline tablet addition give roflumilast tablet 500 mcg orally daily , ask return one week later Visit 3 . The subject ask refrain use his/her long act beta agonist anticholinergics one day ( 24 hour ) prior Visit 3 , use short act beta agonist take caffeine contain drink morning visit 3 . The subject ask inform P. I. adverse event . Visit 3 1 . A brief history physical examination perform subject ask change symptom . 2 . Blood ( 5 ml ) draw peripheral vein HDAC2 measurement . 3 . After baseline spirometry subject give single dose prednisone tablet dose 40 mg. 4 . After 120 minute , spirometry repeat , follow 3 puff albuterol inhaler repeat spirometry . The subject complete study return his/her previous treatment regimen . Data analysis : Results compare term baseline vs drug pair test change FEV1 FEV1/FVC well peripheral blood mononuclear blood HDAC2 level . The relationship FEV1 FEV1/FVC blood HDAC2 level examine correlation analysis . Expected result It expect theophylline roflumilast treatment significant ( p &lt; 0.05 ) increase HDAC2 level . It also expect theophylline roflumilast treatment significant ( p &lt; 0.05 ) increase bronchodilator response steroid dose , thereby support hypothesis . It also possible effect spirometry either treatment ; would indicate increase HDAC2 improve steroid responsiveness .</detailed_description>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Established diagnosis COPD FEV1 &lt; 60 % predict FEV1/FVC &lt; 70 % &lt; +15 % FEV1 response bronchodilator . Patients gender include . IRB approve write informed consent obtain subject . 1 . Recent ( &lt; 1 month ) exacerbation COPD , 2 . Known hypersensitivity beta agonist , theophylline , steroid , roflumilast . 3 . Current recent ( &lt; 2 week ) treatment oral steroid , theophylline methylxanthines , roflumlast . 4 . Diagnosis history asthma , uncontrolled hypertension , congestive heart failure . 5 . History Cardiac arrhythmia 6 . History seizure . 7 . History Liver disease 8 . Gastrointestinal disease , include history peptic ulcer disease . 9 . Current infection antibiotic treatment . 10 . History depression psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>